Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: manfredhasler who wrote (14700)	9/17/2000 11:01:47 AM
From: Robert K.	Respond to of 17367

>). And I think I made it clear that I do have some serious questions regarding study design and study execution.< >>>>>>>>>>>And so do I. The think what we dont know is what was and what was not possible. The fda supposedly had input on the trial design. If this trial didnt show benefit BECAUSE of trial design, then who pays the real penalty here. Is it a. The company b The investors c. The kids and families IMO the penalty I pay, pales in comparison to option (c) Who pays the real penalty? Yes, retrospect is easy.